On the fly News and insights, exclusive to thefly.com

DNLI

Denali Therapeutics

$16.15 /

-0.56 (-3.35%)

, PHAS

PhaseBio

$5.03 /

+0.02 (+0.40%)

10:29
11/12/18
11/12
10:29
11/12/18
10:29

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Denali Therapeutics (DNLI) initiated with a Buy at Janney Montgomery Scott. 2. PhaseBio (PHAS) initiated with a Buy at Stifel and Citi as well as an Outperform at Cowen. 3. Osmotica Pharmaceuticals (OSMT) initiated with a Buy at Jefferies as well as an Outperform at Wells Fargo and RBC Capital. 4. SI-Bone (SIBN) initiated with an Outperform at JMP Securities, an Overweight at Morgan Stanley, as well as a Buy at Canaccord and BofA/Merrill. 5. Studio City (MSC) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

DNLI

Denali Therapeutics

$16.15 /

-0.56 (-3.35%)

PHAS

PhaseBio

$5.03 /

+0.02 (+0.40%)

OSMT

Osmotica Pharmaceuticals

$8.72 /

+ (+0.00%)

SIBN

SI-Bone

$18.33 /

-0.12 (-0.65%)

MSC

Studio City

$18.33 /

-0.67 (-3.53%)

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.